LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 21.40 | 84.90 | 1038 | 1454 | 0.7136 | 0.8419 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 21.40 | 84.90 | 357 | 1454 | 0.2454 | 0.4197 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 21.40 | 84.90 | 1276 | 1454 | 0.8772 | 0.9371 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 23.10 | 84.90 | 37 | 1616 | 0.0229 | -0.1775 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 23.10 | 84.90 | 1075 | 1616 | 0.6651 | 0.8171 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 23.10 | 84.90 | 322 | 1616 | 0.1992 | 0.3684 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 23.10 | 84.90 | 1310 | 1616 | 0.8105 | 0.9036 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.81 | 84.90 | 31 | 1769 | 0.0175 | -0.2054 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.81 | 84.90 | 1105 | 1769 | 0.6245 | 0.7962 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.81 | 84.90 | 355 | 1769 | 0.2006 | 0.3862 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.81 | 84.90 | 1352 | 1769 | 0.7641 | 0.8809 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 26.51 | 84.90 | 33 | 1923 | 0.0172 | -0.1893 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 26.51 | 84.90 | 1121 | 1923 | 0.5829 | 0.7740 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 26.51 | 84.90 | 392 | 1923 | 0.2038 | 0.4047 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 26.51 | 84.90 | 1339 | 1923 | 0.6963 | 0.8455 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 28.21 | 84.90 | 44 | 2091 | 0.0210 | -0.1325 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 28.21 | 84.90 | 1171 | 2091 | 0.5599 | 0.7642 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 28.21 | 84.90 | 476 | 2091 | 0.2276 | 0.4520 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 28.21 | 84.90 | 1393 | 2091 | 0.6660 | 0.8317 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 29.92 | 84.90 | 55 | 2237 | 0.0246 | -0.0879 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 29.92 | 84.90 | 1221 | 2237 | 0.5457 | 0.7591 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 29.92 | 84.90 | 539 | 2237 | 0.2409 | 0.4793 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 29.92 | 84.90 | 1449 | 2237 | 0.6475 | 0.8241 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 31.62 | 84.90 | 64 | 2449 | 0.0261 | -0.0566 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 31.62 | 84.90 | 1269 | 2449 | 0.5180 | 0.7464 | MN20160318_Q02 | D16 |